William Fodor
Chief Tech/Sci/R&D Officer presso HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
William Fodor is the Chief Scientific Officer at Harvard Apparatus Regenerative Technology, Inc. He was previously the Chief Executive Officer at GlyGenix Therapeutics, Inc. and a Senior Director at Alexion Pharmaceuticals, Inc. He also held positions as a Senior Director at ViaCell, Inc. and an Associate Professor at the University of Connecticut.
Fodor earned a doctorate degree from The Ohio State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di William Fodor
| Società | Posizione | Inizio |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Chief Tech/Sci/R&D Officer | 01/07/2017 |
Precedenti posizioni note di William Fodor
| Società | Posizione | Fine |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2008 |
| University of Connecticut | Corporate Officer/Principal | 01/12/2005 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Chief Executive Officer | - |
Formazione di William Fodor
| The Ohio State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
- Borsa valori
- Insiders
- William Fodor
